Literature DB >> 27287545

Activated Circulating Myeloid-Derived Suppressor Cells in Patients with Dilated Cardiomyopathy.

Wen-Cai Zhang, Yan-Ge Wang, Wen-Hui Wei, Xin Xiong, Kan-Ling Liu, Ding-Hang Wang, Xiao-Fan Hu, Yu-Dong Peng, Jing-Jing Wu, Long-Xian Cheng.   

Abstract

BACKGROUND/AIMS: Myeloid-derived suppressor cells (MDSCs) are increased in inflammatory and autoimmune disorders. This study aims to evaluate the significance of MDSCs in dilated cardiomyopathy (DCM) patients.
METHODS: In total, 42 newly hospitalized DCM patients and 39 healthy controls were enrolled in the study. The frequencies of circulating CD14+HLA-DR-/low MDSCs were determined by flow cytometry. Then, the functional properties of MDSCs in suppressing T cell proliferation and interferon-gamma (IFN-x03B3;) production were measured in a co-culture model. Then, mRNA expression levels of various important molecules in peripheral blood mononuclear cells were measured by real time polymerase chain reaction. Furthermore, correlation analyses between MDSC frequencies and cardiac function parameters were also performed.
RESULTS: The frequencies of circulating CD14+HLA-DR-/low MDSCs were significantly elevated in DCM patients compared with healthy controls. It showed that MDSCs from DCM patients more effectively suppressed T cell proliferation and IFN-x03B3; production compared with those from healthy controls, which was partially mediated by arginase-1 (Arg-1). In addition, the correlation analysis suggested that MDSC frequencies were negatively correlated with left ventricular ejection fraction (LVEF), while positively with N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with DCM.
CONCLUSIONS: Circulating activated MDSCs might play significant immunomodulatory roles in the pathogenesis of DCM.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27287545     DOI: 10.1159/000445595

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  2 in total

1.  Blood immune cell biomarkers in lung cancer.

Authors:  D Riemann; M Cwikowski; S Turzer; T Giese; M Grallert; W Schütte; B Seliger
Journal:  Clin Exp Immunol       Date:  2018-11-09       Impact factor: 4.330

2.  Circulating Long Non-coding RNA ENST00000507296 Is a Prognostic Indicator in Patients with Dilated Cardiomyopathy.

Authors:  Xudong Zhang; Xiang Nie; Shuai Yuan; Huaping Li; Jiahui Fan; Chenze Li; Yang Sun; Yanru Zhao; Huiying Hou; Dao Wen Wang; Chen Chen
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-16       Impact factor: 8.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.